Norway· NO-ID_14C7B1F3-2C72-4716-A665-A4B2F84DC90C
Amlyo
A amsacrine product containing amsacrine, registered in Norway by Eurocept. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Amsacrine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XX01 (amsacrine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Amsacrine · ATC L01XX01
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Amsacrine
- Manufacturer
- Eurocept
- Country
- Norway (NO)
- ATC code
- L01XX01
- ATC class
- Amsacrine
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_14C7B1F3-2C72-4716-A665-A4B2F84DC90C
- no_varenummer2580775 x 75
- gtin8718858153053
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAmsalyoEurocept International BV
- IrelandAmsalyo 75 mg powder for concentration for solution infusionEurocept International BV
- IcelandAmsalyoEurocept International B.V.
- SwedenAmsalyo 75 mg Pulver till koncentrat till infusionsvätska, lösningEurocept International B.V.
- United KingdomAmsidine 75mg/1.5ml concentrate and solvent for solution for infusion vialsEurocept International bv
- GermanyAmlyoEurocept International Bv
- NetherlandsAmsalyo 75 mg poeder voor concentraat voor oplossing voor infusieEurocept International B.V.
- BelgiumAmsidine 75 mg/1.5 mlEurocept International
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Amlyo
- Germany · Amlyo, Amsidyl
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Ireland · Amsalyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Sweden · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2b21f96-9849-4de3-8458-cb1167702085 GET /v1/drugs/e2b21f96-9849-4de3-8458-cb1167702085?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Amsakrin",
"merkevare_id": "ID_14C7B1F3-2C72-4716-A665-A4B2F84DC90C",
"name_form_strength": "Amlyo pulv til kons til inf væske, oppl 75 mg",
"prescription_group": "C"
}See everything about amsacrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.